8-14　ⓔ文献

  1. Brewster DC, Cronenwett JL, et al: Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg, 2003; 37: 1106–1117.

  2. 日本循環器学会／日本心臓血管外科学会／日本胸部外科学会／日本血管外科学会合同ガイドライン：2020年改訂版 大動脈瘤・大動脈解離診療ガイドライン．https://www.j-circ.or.jp/cms/wp-content/uploads/2020/07/JCS2020_Ogino.pdf

  3. Davies RR, Goldstein LJ, et al: Yearly rupture or dissection rates for thoracic aortic aneurysms: Simple prediction based on size. Ann Thorac Surg, 2002; 73: 17–27.

  4. Jennette JC, Falk RJ, et al: 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum, 2013; 65: 1–11.

  5. 日本循環器学会：血管炎症候群の診療ガイドライン (2017年改訂版)．http://www.j-circ.or.jp/guideline/pdf/JCS2017_isobe_h.pdf

  6. Yoshifuji H: Pathophysiology of large vessel vasculitis and utility of interleukin–6 inhibition therapy. Mod Rheumatol, 2019; 29: 287–293.

  7. Watanabe Y, Miyata T, et al: Current clinical features of new patients with Takayasu arteritis observed from cross–country research in Japan: Age and sex specificity. Circulation, 2015; 132: 1701–1709.

  8. Nakaoka Y, Isobe M, et al: Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: Results from a randomised, double–blind, placebo–controlled, phase 3 trial in Japan (the TAKT study). Ann Rheum Dis, 2018; 77: 348–354.